Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models
暂无分享，去创建一个
J. Velez | R. Davis | M. Protopopova | M. Konopleva | M. Andreeff | J. Cortes | J. Bankson | T. McQueen | J. Marszalek | S. Konoplev | P. Bhattacharya | C. Hart | Yue-xi Shi | M. Ramirez | Helen Ma | Polina R Matre | H. Mu | R. Jacamo | A. Volgin | J. Benito | Jaehyuk Lee | N. Millward | Hongbo Lu | Karine G. Harutyunyan